

Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Betamethasone Valerate
Therapeutic Area : Dermatology
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Alembic Pharma Gets USFDA Nod for Generic Drug
Details : Betamethasone valerate foam, generic version of Luxiq foam is a glucocorticoid receptor agonist which is indicated for the treatment of moderate to severe psoriasis of scalp.
Product Name : Luxiq-Generic
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 26, 2024
Lead Product(s) : Betamethasone Valerate
Therapeutic Area : Dermatology
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
